Thus, the protective effects of OBS against CIS-induced oxidative stress and inflammation in the liver and kidneys are likely attributable to its modulation of the Nrf2/HO-1 pathway and its inhibition of the NFκB signaling pathway. The gene discussed is NFE2L2; the disease is in situ carcinoma.